Commercialising Regenerative Medicines in the US – What Lessons can We Learn from Europe?
May 1, 2018, 00:00
10.1016/j.jval.2018.04.814
https://www.valueinhealthjournal.com/article/S1098-3015(18)31114-8/fulltext
Title :
Commercialising Regenerative Medicines in the US – What Lessons can We Learn from Europe?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31114-8&doi=10.1016/j.jval.2018.04.814
First page :
Section Title :
Open access? :
No
Section Order :
117